Related Experiment Video
Updated: May 15, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
[Is it presently reasonable to propose prostate cancer screening? Questions and answers]
Christophe E Iselin1, Gregory Wirth
1Service d'urologie, Département de chirurgie, HUG, 1211 Genève 14. christophe.iselin@hcuge.ch
Abstract:
Prostate cancer is the most frequently non-dermatologic tumor diagnosed in Europe. The validity of its screening has been demonstrated by 2 prospective randomized studies including over 160000 patients. However, prostate cancer screening remains controversial because it may lead to overtreatment; moreover, some patients may experience significant functional side effects after surgery and radiotherapy. Integrating this with the individual health situation leads to invite patients to early diagnosis once substantial information has been provided. If cancer is diagnosed, its management is recommended in a multidisciplinary center whose recruitment volume is significant.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Cancer Prevention
Some...
Cancer Prevention
Some...
Preventive Healthcare Services
